These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 739602)

  • 1. [Platelet transfusion and isologous HLA].
    Amamiya Y; Hisamatsu J; Ito T; Baba M; Amaki T
    Rinsho Ketsueki; 1978 Oct; 19(10):1422-8. PubMed ID: 739602
    [No Abstract]   [Full Text] [Related]  

  • 2. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
    Levy L; Woodfield DG
    N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Optimal donor selection and the effectiveness of platelet transfusion in cases refractory to platelet transfusion].
    Iwanaga T; Tsubaki K; Horiuchi A; Fujikawa Y; Kanemitsu Y
    Rinsho Ketsueki; 1986 Jul; 27(7):1274-7. PubMed ID: 3784009
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ineffective platelet transfusion in patients with hematology malignancy].
    Chen S; Xiao L; Zou X
    Zhonghua Yi Xue Za Zhi; 1998 Nov; 78(11):824-6. PubMed ID: 11038776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Measurement of anti-HLA antibody by lymphocytotoxicity test in patients with hematopoietic diseases].
    Kambayashi H; Ohto H; Kariyone S; Tanaka T
    Rinsho Ketsueki; 1989 Jun; 30(6):815-22. PubMed ID: 2795892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of three cross-match techniques to select platelet donors. Lymphocytotoxicity, platelet suspension immunofluorescence test, and enzyme-linked immunosorbent assay.
    Bowen TJ; Berman-Wong E; Dawson D; Herbut B; Smith L; Snider C; Hill L
    Curr Stud Hematol Blood Transfus; 1986; (52):47-57. PubMed ID: 3516584
    [No Abstract]   [Full Text] [Related]  

  • 7. [Blood platelet transfusion in a refractory state--HLA-matched transfusion and high-dose intravenous immunoglobulin].
    Fujii H; Maekawa T; Saji H; Maruya E
    Rinsho Ketsueki; 1986 Jul; 27(7):1268-73. PubMed ID: 3784008
    [No Abstract]   [Full Text] [Related]  

  • 8. [Efficacy of leukocyte-depleted platelet concentrates for prevention of HLA-alloimmunization in patients with frequent platelet transfusions: a prospective multi-institutional study using a polyester platelet filter].
    Handa M; Ikeda Y; Kurata Y; Tsubaki K; Horiuchi A; Furihata K; Kimura Y; Toyama K; Takamoto S; Tsukimoto I
    Rinsho Ketsueki; 1992 Apr; 33(4):451-60. PubMed ID: 1602608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Survival of 51Cr homologous platelets and HLA compatibility (author's transl)].
    Fortýnová J; Májský A; Vopatová M
    Cas Lek Cesk; 1980 Sep; 119(38):1023-9. PubMed ID: 7471144
    [No Abstract]   [Full Text] [Related]  

  • 10. [Severe aplastic anemia treated with HLA-matched platelet transfusion].
    Nozaki H; Yonekura S; Komatsuda M; Watanabe K; Nagao T; Arimori S
    Rinsho Ketsueki; 1986 Aug; 27(8):1410-4. PubMed ID: 3795515
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet transfusions in 75 patients undergoing autologous bone marrow transplantation.
    Lund BV; Madsen M
    Transplant Proc; 1994 Jun; 26(3):1825. PubMed ID: 8030156
    [No Abstract]   [Full Text] [Related]  

  • 12. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].
    Pereira J; Bronfman L; Bertín P; Marzouka E; Hidalgo P; Amaya S; Mezzano D
    Rev Med Chil; 1997 Nov; 125(11):1305-12. PubMed ID: 9609051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and specificity of HLA antibodies in multitransfused patients with acquired aplastic anemia.
    Laundy GJ; Bradley BA; Rees BM; Younie M; Hows JM
    Transfusion; 2004 Jun; 44(6):814-25. PubMed ID: 15157245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experiences in thrombocyte substitution following bone marrow transplantation].
    Luboldt W; Henneberg-Quester KB; Schaefer UW; Beelen D; Mahmoud HK; Schmidt CG
    Beitr Infusionther Klin Ernahr; 1986; 15():165-71. PubMed ID: 3530241
    [No Abstract]   [Full Text] [Related]  

  • 15. Disappearance of anti-HLA antibodies in highly sensitized patients treated with erythropoietin.
    Mourad G; Cristol JP; Chong G; Lorho R; Argiles A; Seignalet J; Mion C
    Transplant Proc; 1992 Dec; 24(6):2512-3. PubMed ID: 1465849
    [No Abstract]   [Full Text] [Related]  

  • 16. Alloimmunization to public HLA antigens in multi-transfused platelet recipients.
    MacPherson BR; Hammond PB; Maniscalco CA
    Ann Clin Lab Sci; 1986; 16(1):38-44. PubMed ID: 3947028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of sensitization to HLA-alloantigens in recipients on the fate of cadaveric renal transplantation].
    Lazić M; Petronić V; Marković V; Krasojević-Kostić I; Buturović J; Vucović D
    Srp Arh Celok Lek; 1986 Feb; 114(2):161-6. PubMed ID: 3523785
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of platelet refractoriness due to HLA antibodies by administration of leukocyte-poor blood components.
    Eernisse JG; Brand A
    Exp Hematol; 1981 Jan; 9(1):77-83. PubMed ID: 7238644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of HLA alloimmunization and other factors on the effectiveness of thrombocyte concentrates].
    Pittrová H; Koza V; Cepelák V; Bufková D
    Cas Lek Cesk; 1990 Jun; 129(24):751-3. PubMed ID: 2393882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism of platelet aggregation induced by HLA-related antibodies.
    Brandt JT; Julius CJ; Osborne JM; Anderson CL
    Thromb Haemost; 1996 Nov; 76(5):774-9. PubMed ID: 8950789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.